What Walgreen's Earnings Reveal About the Health of Its Business

Walgreen reported quarterly earnings results on Tuesday that underwhelmed Wall Street. Here's what you need to know.

Jun 25, 2014 at 5:30PM

Walgreen (NASDAQ:WBA) didn't impress Wall Street when it reported third-quarter earnings yesterday, despite announcing year-over-year increases in both profit and revenue. The stock fell more than 2% in mid-day trading on the news. Nevertheless, long-term investors should keep in mind that Walgreen's stock has gained nearly 55% over the past year. Let's dig deeper to uncover what Walgreen's third-quarter results tell us about the overall health of its business.

Beyond the numbers
In case you missed it, here is a brief recap of Walgreen's third-quarter results. The pharmacy chain generated a quarterly profit of $0.91 per diluted share. This marked a 7% increase from the same period a year ago, in which Walgreen posted adjusted earnings of $0.85 per share. Unfortunately, that was still more than 6% below analyst estimates for earnings-per-share of $0.94 in the period. Walgreen's third-quarter revenue, on the other hand, was in line with Wall Street's expectations at $19.4 billion.

Walgreen's stake in European drugstore chain Alliance Boots contributed $0.15 per diluted share to the company's adjusted earnings in the quarter. As a result, the company now expects second-year cost savings in the range of $400 million to $450 million from its strategic partnership with Alliance Boots, up from its prior guidance of $375 million to $425 million.

While this is encouraging in theory, how Walgreen plans to leverage its stake in Alliance Boots going forward is perhaps far more important. Walgreen's purchased a 45% stake in the European company two years ago and has an option to buy the remaining stake in 2015. Management said it would present investors with its game plan regarding this strategic tie-up as soon as July or early August.

With more details of its partnership with Alliance Boots coming later in the year, let's shift our focus to what we do know from Walgreen's latest earnings release. For starters, increased pressure on gross profit margins in Walgreen's pharmacy business was of concern during the company's earnings call this week. 

Walgreen Gross Profit Pic

Source: Walgreen. 

When margins matter
Higher generic drug costs and lower reimbursement rates squeezed Walgreen's margins in the quarter. Going forward, this means the pharmacy chain will need to better control costs to help offset some of the margin pressure. The company's chief executive Greg Wasson reassured investors by explaining, "We will be accelerating our optimization efforts, including taking additional steps to lower expenses companywide."

Walgreen's gross margin fell 40 basis points to 28 in the period. Yet, this is something that has also plagued rival pharmacy retailers recently, including Rite Aid (NYSE:RAD). Rite Aid reported quarterly results earlier this month that exposed a 55% decline in profit to $0.04 per share. Similar to Walgreen, Rite Aid blamed higher-than-expected drug costs and declining reimbursement rates for the free fall. With industrywide trends such as these, pharmacy retailers such as Walgreen will need to work especially hard to cut costs across its 8,217 stores nationwide. 

Where to from here?
Lower reimbursement rates and pricing pressure from drug suppliers combined with vague details about Walgreen's plans for its expected buyout of Alliance Boots create significant uncertainty for the company today. Therefore, investors may prefer to stay on the sidelines for now, at least until management sheds more light on its plans for the European drugstore chain.

Forget Walgreen: Here's an even better investment idea
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Tamara Rutter has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers